Catherine A. Sohn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Catherine A. Sohn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Catherine A. Sohn. Catherine A. Sohn is in LANDEC CORP \CA\ ($LNDC) and Director in LANDEC CORP \CA\ ($LNDC) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in Neuralstem, Inc. ($CUR) and Director in Axcella Health Inc. ($AXLA) and Director in Rubius Therapeutics, Inc. ($RUBY).
Latest Insider Trading Transactions of Catherine A. Sohn
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXLA, JAZZ, LNDC, SNCA, RUBY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Option Exercise | M | 0.00 | 8,303 | 0 | 0 | ||
| Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Grant | A | 11.64 | 8,303 | 96,647 | 47,010 | 38.7 K to 47 K (+21.45 %) | |
| Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Option Exercise | M | 0.00 | 8,303 | 0 | 0 | ||
| Jun 03 2021 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Grant | A | 11.64 | 8,303 | 96,647 | 47,010 | 38.7 K to 47 K (+21.45 %) | |
| May 13 2021 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Option Exercise | A | 23.25 | 25,000 | 581,250 | 25,000 | |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 46.83 | 8,000 | 374,640 | 0 | |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 152.00 | 8,000 | 1,216,000 | 10,622 | 18.6 K to 10.6 K (-42.96 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 46.83 | 8,000 | 374,640 | 18,622 | 10.6 K to 18.6 K (+75.32 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 156.00 | 4,500 | 702,000 | 10,622 | 15.1 K to 10.6 K (-29.76 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,122 | 10.6 K to 15.1 K (+42.36 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 46.83 | 8,000 | 374,640 | 0 | |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 152.00 | 8,000 | 1,216,000 | 10,622 | 18.6 K to 10.6 K (-42.96 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 46.83 | 8,000 | 374,640 | 18,622 | 10.6 K to 18.6 K (+75.32 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 156.00 | 4,500 | 702,000 | 10,622 | 15.1 K to 10.6 K (-29.76 %) |
| Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,122 | 10.6 K to 15.1 K (+42.36 %) |
| Oct 19 2020 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Option Exercise | M | 0.00 | 2,200 | 0 | 0 | ||
| Oct 19 2020 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Grant | A | 10.36 | 2,200 | 22,792 | 38,707 | 36.5 K to 38.7 K (+6.03 %) | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 125.87 | 931 | 117,186 | 10,622 | 11.6 K to 10.6 K (-8.06 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 2,705 | 0 | 11,553 | 8.8 K to 11.6 K (+30.57 %) |
| Jun 02 2020 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | A | 0.00 | 8,303 | 0 | 8,303 | |
| May 29 2020 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
| May 29 2020 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Grant | A | 10.99 | 6,000 | 65,940 | 36,507 | 30.5 K to 36.5 K (+19.67 %) |
| May 26 2020 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Option Exercise | A | 6.22 | 25,000 | 155,500 | 25,000 | |
| May 22 2020 | AXLA | Axcella Health Inc ... | Sohn Catherine A. | Director | Option Exercise | A | 4.20 | 11,000 | 46,200 | 11,000 | |
| Jan 21 2020 | AXLA | Axcella Health Inc ... | Sohn Catherine A. | Director | Buy | P | 4.87 | 1,000 | 4,870 | 1,000 | 0 to 1,000 |
| Oct 17 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | A | 0.00 | 2,200 | 0 | 2,200 | |
| Oct 07 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 9.01 | 10,000 | 90,100 | 0 | |
| Oct 07 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Payment of Exercise | F | 10.21 | 8,824 | 90,093 | 30,507 | 39.3 K to 30.5 K (-22.44 %) |
| Oct 07 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 9.01 | 10,000 | 90,100 | 39,331 | 29.3 K to 39.3 K (+34.09 %) |
| Aug 23 2019 | AXLA | Axcella Health Inc ... | Sohn Catherine A. | Director | Option Exercise | A | 8.11 | 22,000 | 178,420 | 22,000 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 135.65 | 726 | 98,482 | 8,848 | 9.6 K to 8.8 K (-7.58 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,920 | 0 | 9,574 | 7.7 K to 9.6 K (+25.08 %) |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,240 | 0 | 0 | |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,240 | 0 | 0 | |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 9.91 | 4,240 | 42,018 | 29,331 | 25.1 K to 29.3 K (+16.90 %) |
| May 30 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 9.91 | 4,240 | 42,018 | 29,331 | 25.1 K to 29.3 K (+16.90 %) |
| May 28 2019 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Option Exercise | A | 16.27 | 25,000 | 406,750 | 25,000 | |
| Jan 11 2019 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | P | 11.23 | 1,000 | 11,230 | 25,091 | 24.1 K to 25.1 K (+4.15 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 176.61 | 660 | 116,563 | 7,654 | 8.3 K to 7.7 K (-7.94 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,495 | 0 | 8,314 | 6.8 K to 8.3 K (+21.92 %) |
| Jul 23 2018 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Buy | P | 23.00 | 2,500 | 57,500 | 2,500 | 0 to 2.5 K |
| Jul 18 2018 | RUBY | Rubius Therapeutic ... | Sohn Catherine A. | Director | Option Exercise | A | 23.00 | 25,000 | 575,000 | 25,000 | |
| Jun 01 2018 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,240 | 0 | 4,240 | |
| May 25 2018 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,286 | 0 | 0 | |
| May 25 2018 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 13.65 | 4,286 | 58,504 | 24,091 | 19.8 K to 24.1 K (+21.64 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 144.22 | 3 | 433 | 6,819 | 6.8 K to 6.8 K (-0.04 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 142.36 | 659 | 93,815 | 6,822 | 7.5 K to 6.8 K (-8.81 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,365 | 0 | 7,481 | 6.1 K to 7.5 K (+22.32 %) |
| Jun 05 2017 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,286 | 0 | 4,286 | |
| May 26 2017 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 5,282 | 0 | 0 | |
| May 26 2017 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 13.50 | 5,282 | 71,307 | 19,805 | 14.5 K to 19.8 K (+36.37 %) |
| Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 136.45 | 633 | 86,373 | 6,116 | 6.7 K to 6.1 K (-9.38 %) |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,365 | 0 | 6,749 | 5.4 K to 6.7 K (+25.35 %) |
| May 31 2016 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 5,222 | 0 | 5,222 | |
| May 31 2016 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 3,475 | 0 | 0 | |
| May 31 2016 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 11.46 | 3,475 | 39,824 | 14,523 | 11 K to 14.5 K (+31.45 %) |
| Nov 23 2015 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 3,333 | 0 | 0 | |
| Nov 23 2015 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 11.93 | 3,333 | 39,763 | 11,048 | 7.7 K to 11 K (+43.20 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 177.71 | 10 | 1,777 | 5,384 | 5.4 K to 5.4 K (-0.19 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 177.82 | 644 | 114,516 | 5,394 | 6 K to 5.4 K (-10.67 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 184.06 | 4 | 736 | 6,038 | 6 K to 6 K (-0.07 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 179.98 | 797 | 143,444 | 6,042 | 6.8 K to 6 K (-11.65 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,310 | 0 | 6,839 | 5.5 K to 6.8 K (+23.69 %) |
| Jul 06 2015 | CUR | Neuralstem, Inc. | Sohn Catherine A. | Director | Grant | A | 0.00 | 106,952 | 0 | 106,952 | 0 to 107 K |
| May 29 2015 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 3,475 | 0 | 3,475 | |
| May 29 2015 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Option Exercise | M | 0.00 | 4,219 | 0 | 0 | |
| May 29 2015 | LNDC | LANDEC CORP \CA\ | Sohn Catherine A. | Director | Buy | M | 14.29 | 4,219 | 60,290 | 7,715 | 3.5 K to 7.7 K (+120.68 %) |
Page: 1